Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Pioglitazone, Nuclear Receptors, and Aerodigestive Prevention.

Ondrey FG.

Cancer Prev Res (Phila). 2019 Sep 19. doi: 10.1158/1940-6207.CAPR-19-0341. [Epub ahead of print]

PMID:
31537582
2.

Chemoprevention of Lung Carcinogenesis by Dietary Nicotinamide and Inhaled Budesonide.

Galbraith AR, Seabloom DE, Wuertz BR, Antonides JD, Steele VE, Wattenberg LW, Ondrey FG.

Cancer Prev Res (Phila). 2019 Feb;12(2):69-78. doi: 10.1158/1940-6207.CAPR-17-0402. Epub 2019 Jan 3.

PMID:
30606719
3.

PPARγ-Mediated p21 Induction in Aerodigestive Preneoplastic Cell Lines.

Miller WA, Wuertz BR, Ondrey FG.

Ann Otol Rhinol Laryngol. 2018 Oct;127(10):677-686. doi: 10.1177/0003489418787833. Epub 2018 Jul 26.

PMID:
30047791
4.

Pepsin: biomarker, mediator, and therapeutic target for reflux and aspiration.

Johnston N, Dettmar PW, Ondrey FG, Nanchal R, Lee SH, Bock JM.

Ann N Y Acad Sci. 2018 Dec;1434(1):282-289. doi: 10.1111/nyas.13729. Epub 2018 May 17. Review.

PMID:
29774546
5.

Effects of talactoferrin alpha on lung adenoma prevention in A/J mice June 2, 2016.

Seabloom DE, Galbraith AR, Haynes AM, Fujita AS, Antonides JD, Wuertz BR, Steele VE, Ondrey FG, Wattenberg LW.

Am J Transl Res. 2018 Mar 15;10(3):875-880. eCollection 2018.

6.

Thiazolidinediones abrogate cervical cancer growth.

Wuertz BR, Darrah L, Wudel J, Ondrey FG.

Exp Cell Res. 2017 Apr 15;353(2):63-71. doi: 10.1016/j.yexcr.2017.02.020. Epub 2017 Feb 20.

PMID:
28219679
7.

Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention.

Seabloom DE, Galbraith AR, Haynes AM, Antonides JD, Wuertz BR, Miller WA, Miller KA, Steele VE, Miller MS, Clapper ML, O'Sullivan MG, Ondrey FG.

Cancer Prev Res (Phila). 2017 Feb;10(2):116-123. doi: 10.1158/1940-6207.CAPR-16-0232. Epub 2017 Jan 4.

8.

Safety and Preclinical Efficacy of Aerosol Pioglitazone on Lung Adenoma Prevention in A/J Mice.

Seabloom DE, Galbraith AR, Haynes AM, Antonides JD, Wuertz BR, Miller WA, Miller KA, Steele VE, Suen CS, O'Sullivan MG, Ondrey FG.

Cancer Prev Res (Phila). 2017 Feb;10(2):124-132. doi: 10.1158/1940-6207.CAPR-16-0174. Epub 2016 Dec 19.

9.

Correlation analysis of oral lesion sizes by various standardized criteria.

Flanagan CE, Rhodus NL, Cole KA, Szabo E, Ondrey FG.

Am J Otolaryngol. 2016 Nov - Dec;37(6):502-506. doi: 10.1016/j.amjoto.2016.07.004. Epub 2016 Jul 12.

10.

Functional activation of PPARγ in human upper aerodigestive cancer cell lines.

Wright SK, Wuertz BR, Harris G, Abu Ghazallah R, Miller WA, Gaffney PM, Ondrey FG.

Mol Carcinog. 2017 Jan;56(1):149-162. doi: 10.1002/mc.22479. Epub 2016 Mar 21.

11.

N-methylnitrosourea–induced carcinoma as a model for laryngeal carcinogenesis.

Caicedo-Granados E, Galbraith AR, Schachern MG, Hartle DE, Wattenberg LW, Wuertz BR, Keel S, Yueh B, Ondrey FG.

Head Neck. 2014 Dec;36(12):1802-6.

PMID:
25548813
12.

Mechanism and efficacy of sub-50-nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinoma.

Unger GM, Kren BT, Korman VL, Kimbrough TG, Vogel RI, Ondrey FG, Trembley JH, Ahmed K.

Mol Cancer Ther. 2014 Aug;13(8):2018-29. doi: 10.1158/1535-7163.MCT-14-0166. Epub 2014 May 27.

13.

Quantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral cancer biomarker.

Yang Y, Rhodus NL, Ondrey FG, Wuertz BR, Chen X, Zhu Y, Griffin TJ.

PLoS One. 2014 Apr 18;9(4):e95389. doi: 10.1371/journal.pone.0095389. eCollection 2014.

14.

Not significant but important.

Mulshine JL, Ondrey FG.

Cancer Prev Res (Phila). 2013 May;6(5):371-4. doi: 10.1158/1940-6207.CAPR-13-0106.

15.

Id2 regulates the proliferation of squamous cell carcinoma in vitro via the NF-κB/Cyclin D1 pathway.

Wang C, Chen Q, Hamajima Y, Sun W, Zheng YQ, Hu XH, Ondrey FG, Lin JZ.

Chin J Cancer. 2012 Sep;31(9):430-9. doi: 10.5732/cjc.011.10454. Epub 2012 Jul 26.

16.

A comparison of screening methods in two early phase oral leukoplakia clinical trials.

Rosas RR, Cole KA, Darrah L, Rohrer MD, Rhodus NL, Ondrey FG.

Oral Dis. 2012 Oct;18(7):720-3. doi: 10.1111/j.1601-0825.2012.01934.x. Epub 2012 Apr 24.

17.

Enforced expression of nuclear factor kappa B in p53 deficient keratinocytes induces cell cycle, angiogenic potential and tumorigenesis.

Caicedo-Granados EE, Wuertz BR, Ondrey FG.

Oral Oncol. 2012 Apr;48(4):303-10. doi: 10.1016/j.oraloncology.2011.11.008. Epub 2011 Dec 3.

PMID:
22143006
18.

The effect of indomethacin on paclitaxel sensitivity and apoptosis in oral squamous carcinoma cells: the role of nuclear factor-κB inhibition.

Caicedo-Granados EE, Wuertz BR, Marker PH, Lee GS, Ondrey FG.

Arch Otolaryngol Head Neck Surg. 2011 Aug;137(8):799-805. doi: 10.1001/archoto.2011.131.

PMID:
21844414
19.

Tobacco carcinogen mediated up-regulation of AP-1 dependent pro-angiogenic cytokines in head and neck carcinogenesis.

Swenson WG, Wuertz BR, Ondrey FG.

Mol Carcinog. 2011 Sep;50(9):668-79. doi: 10.1002/mc.20775. Epub 2011 Apr 7.

PMID:
21480395
20.

Interleukin-8 production in response to tumor necrosis factor-alpha by cholesteatoma keratinocytes in cell culture.

Hilton CW, Ondrey FG, Wuertz BR, Levine SC.

Laryngoscope. 2011 Feb;121(2):372-4. doi: 10.1002/lary.21352. Epub 2011 Jan 13.

PMID:
21271591
21.

The role of inhibitor of DNA-binding (Id1) in hyperproliferation of keratinocytes: the pathological basis for middle ear cholesteatoma from chronic otitis media.

Hamajima Y, Komori M, Preciado DA, Choo DI, Moribe K, Murakami S, Ondrey FG, Lin J.

Cell Prolif. 2010 Oct;43(5):457-63. doi: 10.1111/j.1365-2184.2010.00695.x.

22.

Conference Report: Eighth Annual AACR International Conference on Frontiers in Cancer Prevention Research.

Brewster AM, Patterson SL, Forman MR, Hughes-Halbert C, Limburg PJ, Ondrey FG, Paskett ED, Wetter DW, Hawk ET.

Cancer Prev Res (Phila). 2010 Aug;3(8):1044-8. doi: 10.1158/1940-6207.CAPR-10-0141. Epub 2010 Jul 27.

23.

Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions.

de Jong EP, Xie H, Onsongo G, Stone MD, Chen XB, Kooren JA, Refsland EW, Griffin RJ, Ondrey FG, Wu B, Le CT, Rhodus NL, Carlis JV, Griffin TJ.

PLoS One. 2010 Jun 17;5(6):e11148. doi: 10.1371/journal.pone.0011148.

24.

A metaproteomic analysis of the human salivary microbiota by three-dimensional peptide fractionation and tandem mass spectrometry.

Rudney JD, Xie H, Rhodus NL, Ondrey FG, Griffin TJ.

Mol Oral Microbiol. 2010 Feb;25(1):38-49. doi: 10.1111/j.2041-1014.2009.00558.x.

25.

Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways.

Lin J, Guan Z, Wang C, Feng L, Zheng Y, Caicedo E, Bearth E, Peng JR, Gaffney P, Ondrey FG.

Clin Cancer Res. 2010 Jan 1;16(1):77-87. doi: 10.1158/1078-0432.CCR-08-2362. Epub 2009 Dec 22.

26.

Expression of fibroblast growth factor binding protein in head and neck cancer.

Li W, Wang C, Juhn SK, Ondrey FG, Lin J.

Arch Otolaryngol Head Neck Surg. 2009 Sep;135(9):896-901. doi: 10.1001/archoto.2009.121.

27.

The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Juhn SK, Jung MK, Hoffman MD, Drew BR, Preciado DA, Sausen NJ, Jung TT, Kim BH, Park SY, Lin J, Ondrey FG, Mains DR, Huang T.

Clin Exp Otorhinolaryngol. 2008 Sep;1(3):117-38. doi: 10.3342/ceo.2008.1.3.117. Epub 2008 Sep 30.

28.

Ototoxicity after combined platinum and fractionated radiation in a novel guinea pig model.

Miller MW, Riedel G, Hoistad D, Sutherland C, Juhn SK, Adams GL, Griffin R, Ondrey FG.

Am J Otolaryngol. 2009 Jan-Feb;30(1):1-7. doi: 10.1016/j.amjoto.2007.12.003. Epub 2008 Jun 20.

PMID:
19027506
29.

Pilot randomized phase II study of celecoxib in oral premalignant lesions.

Papadimitrakopoulou VA, William WN Jr, Dannenberg AJ, Lippman SM, Lee JJ, Ondrey FG, Peterson DE, Feng L, Atwell A, El-Naggar AK, Nathan CO, Helman JI, Du B, Yueh B, Boyle JO.

Clin Cancer Res. 2008 Apr 1;14(7):2095-101. doi: 10.1158/1078-0432.CCR-07-4024.

30.

Presence of otitis media with effusion and its risk factors affect serum cytokine profile in children.

Johnston BN, Preciado DA, Ondrey FG, Daly KA.

Int J Pediatr Otorhinolaryngol. 2008 Feb;72(2):209-14. Epub 2007 Dec 4.

PMID:
18055023
31.

A method of producing carcinoma in upper aerodigestive tree and esophagus of the Syrian golden hamster using wounding and instillation of N-methylnitrosourea.

Estensen RD, Anderson WR, Galbraith AR, Hartle DE, Jordan MM, Ondrey FG, Wattenberg LW.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1644-50.

32.

Inositol hexaphosphate and paclitaxel: symbiotic treatment of oral cavity squamous cell carcinoma.

Janus SC, Weurtz B, Ondrey FG.

Laryngoscope. 2007 Aug;117(8):1381-8.

PMID:
17607147
33.

Efficacy of an osmotic pump delivered, GM-CSF-based tumor vaccine in the treatment of upper aerodigestive squamous cell carcinoma in rats.

Djalilian HR, Caicedo E, Lessan K, Grami V, Le CT, Spellman SR, Pambuccian S, Hall WA, Low WC, Ondrey FG.

Cancer Immunol Immunother. 2007 Aug;56(8):1207-14. Epub 2007 Jan 12.

PMID:
17219150
34.

Id1 induces the proliferation of cochlear sensory epithelial cells via the nuclear factor-kappaB/cyclin D1 pathway in vitro.

Ozeki M, Hamajima Y, Feng L, Ondrey FG, Schlentz E, Lin J.

J Neurosci Res. 2007 Feb 15;85(3):515-24. Erratum in: J Neurosci Res. 2012 Nov;90(11):2225.

PMID:
17149750
36.

Sensorineural hearing loss in Vogt-Koyanagi-Harada syndrome.

Ondrey FG, Moldestad E, Mastroianni MA, Pikus A, Sklare D, Vernon E, Nusenblatt R, Smith J.

Laryngoscope. 2006 Oct;116(10):1873-6.

PMID:
17003710
37.

Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma.

Patel KJ, Pambuccian SE, Ondrey FG, Adams GL, Gaffney PM.

Oral Oncol. 2006 Nov;42(10):994-1004. Epub 2006 Jun 9.

PMID:
16762588
38.

Decreased hearing after combined modality therapy for head and neck cancer.

Pearson SE, Meyer AC, Adams GL, Ondrey FG.

Am J Otolaryngol. 2006 Mar-Apr;27(2):76-80.

PMID:
16500467
39.

PPAR activation and decreased proliferation in oral carcinoma cells with 4-HPR.

Harris G, Ghazallah RA, Nascene D, Wuertz B, Ondrey FG.

Otolaryngol Head Neck Surg. 2005 Nov;133(5):695-701.

PMID:
16274795
40.

Characterization of a temperature-sensitive mouse middle ear epithelial cell line.

Tsuchiya K, Kim Y, Ondrey FG, Lin J.

Acta Otolaryngol. 2005 Aug;125(8):823-9.

PMID:
16158528
41.

Induction of heat shock protein 70 inhibits NF-kappa-B in squamous cell carcinoma.

King TA, Ghazaleh RA, Juhn SK, Adams GL, Ondrey FG.

Otolaryngol Head Neck Surg. 2005 Jul;133(1):70-9.

PMID:
16025056
42.

A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma.

Druzgal CH, Chen Z, Yeh NT, Thomas GR, Ondrey FG, Duffey DC, Vilela RJ, Ende K, McCullagh L, Rudy SF, Muir C, Herscher LL, Morris JC, Albert PS, Van Waes C.

Head Neck. 2005 Sep;27(9):771-84.

PMID:
15920746
43.

A new immune-competent animal model of mucosally derived squamous cell carcinoma.

Djalilian HR, Lessan K, Grami V, Pambuccian SE, Spellman SR, Low WC, Hall WA, Ondrey FG.

Otolaryngol Head Neck Surg. 2004 Nov;131(5):781-3.

PMID:
15523466
44.

Irreversible ototoxicity associated with difluoromethylornithine.

Lao CD, Backoff P, Shotland LI, McCarty D, Eaton T, Ondrey FG, Viner JL, Spechler SJ, Hawk ET, Brenner DE.

Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1250-2.

45.

Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck.

Ginos MA, Page GP, Michalowicz BS, Patel KJ, Volker SE, Pambuccian SE, Ondrey FG, Adams GL, Gaffney PM.

Cancer Res. 2004 Jan 1;64(1):55-63.

46.

Auditory dysfunction in Stickler syndrome.

Szymko-Bennett YM, Mastroianni MA, Shotland LI, Davis J, Ondrey FG, Balog JZ, Rudy SF, McCullagh L, Levy HP, Liberfarb RM, Francomano CA, Griffith AJ.

Arch Otolaryngol Head Neck Surg. 2001 Sep;127(9):1061-8.

PMID:
11556853
47.

Prospective comparison of panoramic tomography (zonography) and helical computed tomography in the diagnosis and operative management of mandibular fractures.

Wilson IF, Lokeh A, Benjamin CI, Hilger PA, Hamlar DD, Ondrey FG, Tashjian JH, Thomas W, Schubert W.

Plast Reconstr Surg. 2001 May;107(6):1369-75.

PMID:
11335803
48.

Recommendations for cancer prevention trials using potentially ototoxic test agents.

Shotland LI, Ondrey FG, Mayo KA, Viner JL.

J Clin Oncol. 2001 Mar 15;19(6):1658-63.

PMID:
11250994
49.

Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer.

Sunwoo JB, Herscher LL, Kroog GS, Thomas GR, Ondrey FG, Duffey DC, Solomon BI, Boss C, Albert PS, McCullugh L, Rudy S, Muir C, Zhai S, Figg WD, Cook JA, Mitchell JB, Van Waes C.

J Clin Oncol. 2001 Feb 1;19(3):800-11.

PMID:
11157034
50.

Cisplatin and radiation sensitivity in human head and neck squamous carcinomas are independently modulated by glutathione and transcription factor NF-kappaB.

Kato T, Duffey DC, Ondrey FG, Dong G, Chen Z, Cook JA, Mitchell JB, Van Waes C.

Head Neck. 2000 Dec;22(8):748-59.

PMID:
11084634

Supplemental Content

Loading ...
Support Center